glp-1 drugs competitive intelligence 2025 Market Size, Share GLP-1 Analogues Market Size to

The slower you go, the less turbulence you create, and the more intact your peptide molecules remain

10.1016/j.phrs.2022.106062 150 RobichauxW

Key Market Segments Product Type Semaglutide Liraglutide Exenatide Dulaglutide Others Route of Administration Parenteral Oral Application Type 2 diabetes mellitus Obesity Others Distribution Channel Hospital pharmacies Online pharmacies Retail pharmacies Drivers Increasing Global Prevalence of Type 2 Diabetes Mellitus and Obesity is Driving the Market The escalating global prevalence of type 2 diabetes mellitus and obesity is a major driver for the GLP-1 Receptor Agonist Market

The average absorption rate of a oral supplement is only 45 % compared with 90% via an IM shot